VVector Bio offers excellent services for Adeno-associated virus (AAV), Lentivirus and Adenovirus production to support cell and gene therapy development
► Publication (Cell & Gene Therapy Insights 2025): A simplified chromatography method for robust separation of full and empty AAV capsids: a case study with AAV2
► International Consortium to revolutionize viral vector manufacturing – VVector Bio is leading a ground-breaking collaboration joined by the NRC, Revvity and Abselion.
► VVector Bio is also present at Maison Notman House
► Dean’s Report (Fall 2021): Technology to Transform Global Healthcare
► VVector Bio is a McGill Spinoff Company
► Winners of the 2019-2020 William and Rhea Seath Awards Competition
VVECTOR BIO, Bridging Research and Clinic
2020 VVECTOR BIO. All Rights Reserved